Some statistics in bioinformatics: The fifth Armitage Lecture

Statistics in Medicine

Volumn 28, Issue 23, 2009, Pages 2833-2856

  Solomon, Patricia J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

AIDS epidemiology; Bioinformatics; Embryonic stem cells; Gene expression; Gene profiling; Microarray data analysis; Pluripotency; Proteomic profiles for ovarian cancer; Sequential trial; Serum proteomic test for ovarian cancer; Some statistical truths; Survival analysis

Indexed keywords

ARTICLE; BIOINFORMATICS; BIOSTATISTICS; EMBRYONIC STEM CELL; EPIDEMIOLOGICAL DATA; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE REGULATORY NETWORK; HUMAN; MICROARRAY ANALYSIS; NONHUMAN; OVARY CANCER; PROTEIN ANALYSIS; STRUCTURAL PROTEOMICS; SURVIVAL; TIME SERIES ANALYSIS;

ANIMALS; COMPUTATIONAL BIOLOGY; CONTROLLED CLINICAL TRIALS AS TOPIC; EMBRYONIC STEM CELLS; EPIDEMIOLOGIC METHODS; FEMALE; GENE EXPRESSION PROFILING; GREAT BRITAIN; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MICE; MODELS, STATISTICAL; OVARIAN NEOPLASMS; PLURIPOTENT STEM CELLS; PROTEIN INTERACTION MAPPING; PROTEOMICS; SURVIVAL ANALYSIS; SYSTEMS BIOLOGY;

EID: 70449382682     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3668     Document Type: Article

References (38)

1. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fudaro VA, Steinberg VM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. The Lancet 2002; 359(9306):572-577. (Pubitemid 34178440)
2. Tuke J, Glonek GVF, Solomon PJ. Gene profiling for determining pluripotent genes in a time course microarray experiment. Biostatistics 2009; 10:80-93. DOI: 10.1093/biostatistics/kxn017. (Pubitemid 352847908)
3. Armitage P. Sequential Medical Trials. Blackwell: Oxford, 1960.
4. Armitage Day DVD. A conversation with Peter Armitage. Interviewed by Professor Vern Farewell and Professor David Spiegelhalter, DVD, Cambridge, 2007.
5. Armitage P. Sequential Medical Trials (2nd edn). Wiley: New York, 1975.
6. Armitage P. The comparison of survival curves. Journal of the Royal Statistical Society, Series A 1959; 122(3):279-300.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53:457-481.
8. Report of a Working Group (the Cox Report). Short-Term Prediction of HIV Infection and AIDS in England and Wales. Her Majesty's Stationery Office: London, 1988.
9. Cox DR. Regression models and life-tables (with Discussion). Journal of the Royal Statistical Society, Series B 1972; 34:187-220.
10. Bradford Hill A. Discussion of 'The comparison of survival curves' by P. Armitage. Journal of the Royal Statistical Society, Series A 1959; 122(3):279-300.
11. ISIS-3 Collaborative Group. ISIS-3: a randomised comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41,299 cases of suspected acute myocardial infarction. The Lancet 1991; 339:753-770.
12. Byar DP, Schoenfeld DA, Green SB, Amato DA, Anderson JR, Collins R, Davis R, DeGruttola V, Ellenberg SS, Finkelstein DM, Freedman LS, Gail M, Gatsonis C, Gelber RD, Lagakos S, Lefkopoulou M, Peto J, Peto R, Peto T, Simon R, Tsiatis AA, Zelen M. Design considerations for AIDS trials. New England Journal of Medicine 1990; 323:1343-1348.
13. Solomon PJ, Wilson SR. Accommodating change due to treatment in the method of back projection for estimating HIV infection incidence. Biometrics 1990; 46:1165-1170.
14. Brookmeyer R, Liao JG. Statistical modelling of the AIDS epidemic for forecasting health care needs. Biometrics 1990; 40:1151-1163.
15. Becker NG, Watson LF, Carlin JB. A method of non-parametric back-projection and its application to AIDS data. Statistics in Medicine 1991; 10:1527-1542.
16. Solomon PJ, Isham V. Disease surveillance and data collection issues in epidemic modelling. Statistical Methods in Medical Research 2000; 9:259-277. (Pubitemid 30779819)
17. Longini IM, Clark WS, Satten GA, Byers RH, Karon J. Staged Markov models based on CD4+ T-lymphocytes for the natural history of HIV infection. In Models for Infectious Human Diseases: Their Structure and Relation to Data, Isham V, Medley G (eds). Cambridge University Press: Cambridge, 1996; 429-449.
18. Silver JD, Ritchie ME, Smyth GK. Microarray background correction: maximum likelihood estimation for the normal-exponential convolution. Biostatistics 2009; DOI: 10.1093/biostatistics/kxn042.
19. Speed TP. Gene networks and microarray data analysis. Walter and Eliza Hall Institute Seminar, Melbourne, Australia, 7 November 2006.
20. Zhang Z, Bast Jr RC, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng X-Y, Berchuck A, van Haaften-Day C, Hacker NF, de Bruijn HWA, van der Zee AGJ, Jacobs IJ, Fung ET, Chan DW. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Research 2004; 64:5882-5890. (Pubitemid 39095590)
21. Sorace JM, Zhan M. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics 2003; 4:24.
22. Baggerly KA, Morris JS, Coomes KR. Reproducibility of SELDI-TOF protein pattern in serum: comparing datasets from different experiments. Bioinformatics 2004; 20(5):777-785.
23. Baggerly KA, Morris JS, Edmonson SR, Coomes KR. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. Journal of the National Cancer Institute 2005; 97(4):307-309.
24. Conrads TP, Fusaro VA, Ross S, Johann D, Rajapaske V, Hitt BA, Steinberg SM, Kohn EC, Fishman DA, Whitely G, Barrett JC, Liotta LA, Petricoin EF, Veenstra TD. High-resolution serum proteomic features for ovarian cancer detection. Endocrine Related Cancer 2004; 11(2):163-178. (Pubitemid 38832824)
25. Baggerly KA. Proteomics, ovarian cancer and experimental design. M.D. Anderson Cancer Center Seminar, Houston, TX, 2005.
26. Armitage P, Berry G, Matthews JNS. Statistical Methods for Medical Research (4th edn). Blackwell: Oxford, 2002;
27. Glonek GF, Solomon PJ. Factorial and time course designs for cDNA microarray experiments. Biostatistics 2004; 5:89-111.
28. Fleury G, Hero A, Yoshida S, Carter T, Barlow C, Swaroop A. Pareto analysis for gene filtering in microarray experiments. Proceedings of the 11th European Signal Processing Conference, Toulouse, France, vol.3, 2002; 165-168.
29. Hero AO, Fleury G. Pareto-optimal methods for gene ranking. The Journal of VLSI Signal Processing 2004; 38:259-275.
30. Lönnstedt I, Grant S, Begley G, Speed TP. Microarray analysis of two interacting treatments: a linear model and trends in expression over time. Technical Report 7/2001, Department of Mathematics, Uppsala University, Uppsala, Sweden, 2001.
31. Wellek S. Testing Statistical Hypotheses of Equivalence. CRC Press: Boca Raton, FL, 2002.
32. Berger RL. Multiparameter hypothesis testing and acceptance sampling. Technometrics 1982; 24:295-300.
33. Nishimoto M, Miyagi S, Yamagishi T, Sakaguchi T, Niwa H, Muramatsu M, Okuda A. Oct-3/4 maintains the proliferative embryonic stem cell state via specific binding to a variant octamer sequence in the regulatory region of the UTF1 locus. Molecular and Cellular Biology 2005; 25:5084-5094. (Pubitemid 40781108)
34. Rodda DJ, Chew J-L, Lim L-H, Loh Y-H, Wang B, Ng H-H, Robson P. Transcriptional regulation of Nanog by Oct4 and Sox2. The Journal of Biological Chemistry 2005; 280:24731-24737.
35. Loh Y-H, Wu Q, Chew J-L, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong K-Y, Sung KW, Lee CWH, Zhao X-D, Chiu K-P, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei C-L, Ruan Y, Lim B, Ng H-H. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics 2006; 38:431-440.
36. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006; 444(7117):364-368. (Pubitemid 44764111)
37. Glonek GF, Solomon PJ. Discussion of 'Resampling-based multiple testing for microarray data analysis' by Ge, Dudoit and Speed. TEST 2003; 12(1):44-47.
38. Marot G, Mayer C-D. Sequential analysis for Microarray data based on sensitivity and meta-analysis. Statistical Applications in Genetics and Molecular Biology 2009; DOI: 10.2202/154-6115.1368.